Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Samit Hirawat Insider Profile
11 Followers
Samit Hirawat, EVP,Chief Med.Offr.,Drug Dev at Bristol-Myers Squibb, holds 62.11K shares in Bristol-Myers Squibb (Ticker: BMY). Most recently, Samit Hirawat Bought $1,830 shares of Bristol-Myers Squibb on Nov 05, 2024 for an estimated value of 100.05K.
Samit Hirawat has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP,Chief Med.Offr.,Drug Dev
Roles that Samit Hirawat holds in companies
Most Profitable Insider Trade
The most profitable trade made by Samit Hirawat
Samit Hirawat's Trading History
List of latest transactions for each holding click on a transaction to see Samit Hirawat's performance on stock
You May Also Like
Samit Hirawat insider profile FAQ
What is the percentage of profitable transactions made by Samit Hirawat?
The percentage of profitable transactions made by Samit Hirawat is ―.
What is the average return per transaction made by Samit Hirawat?
The average return per transaction made by Samit Hirawat is ―.
What stocks does Samit Hirawat hold?
Samit Hirawat holds: BMY stocks.
What was Samit Hirawat’s latest transaction?
Samit Hirawat latest transaction was an Informative Buy of $100.05K.
What was Samit Hirawat's most profitable transaction?
Samit Hirawat’s most profitable transaction was an Informative Buy of BMY stock on November 5, 2024. The return on the trade was 2.40%.
What is Samit Hirawat's role in Bristol-Myers Squibb?
Samit Hirawat's role in Bristol-Myers Squibb is EVP,Chief Med.Offr.,Drug Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.